Biovica acquires cSens AB - creating opportunities for solving cancer diagnostic chal
 

Biovica has acquired cSens AB, a company that has developed a PCR-based platform for the analysis of serum thymidine kinase (TK) enzyme activity, which correspond to tumor proliferation and cancer aggressiveness.

More...